No Prescription |
 |
 | ||
|
FEFOL SPANSULE Feosal |
|
| ||
No Prescription » Prescription Drugs 7 » FEFOL SPANSULE Feosal Fefol provides the iron needed by the body to produce red blood cells. It is used to treat or prevent iron-deficiency anemia a condition that occurs when the body has too few red blood cells because of pregnancy poor diet excess bleeding or other medical problems.Ferrous sulfate comes in regular coated and extended-release (long-acting) tablets; regular and extended-release capsules; and oral liquid (syrup drops and elixir). Ferrous sulfate usually is taken three times a day between meals. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take ferrous sulfate exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Although symptoms of iron deficiency usually improve within a few days you may have to take ferrous sulfate for 6 months if you have severe iron deficiency.This medication should be taken on an empty stomach at least 1 hour before or 2 hours after eating.Ferrous sulfate drops come with a special dropper for measuring the dose. Ask your pharmacist to show you how to use it. The drops may be placed directly in the mouth or mixed with water or fruit juice (not with milk).Do not crush or chew regular coated or extended-release tablets and do not open regular or extended-release capsules; swallow them whole. Buy FEFOL SPANSULE Feosal and other Prescription Drugs 7 products online at Medstore. 520
About FEFOL SPANSULE Feosal: Product Type: Prescription Drugs 7 FEFOL SPANSULE ( Feosal Ferrex Niferex Hytinic Ircon Mol-iron Hemocyte Icar Feratab Fergon Generic Ferrous Sulphate/Folic Acid ) FEFOL SPANSULE (Feosal Ferrex Niferex Hytinic Ircon Mol-iron Hemocyte Icar Feratab Fergon Generic Ferrous Sulphate/Folic Acid) Feosal Ferrex Niferex Hytinic Ircon Mol-iron Hemocyte Icar Feratab Fergon Generic Ferrous Sulphate/Folic Acid 150mg/0.5mg Spans Caps 90 (3 x 30) Feosal Ferrex Niferex Hytinic Ircon Mol-iron Hemocyte Icar Feratab Fergon Generic Ferrous Sulphate/Folic Acid FEFOL SPANSULE
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
